Quaterly Results | Windlas Biotech Ltd. | R Wadiwala Securities Pvt Ltd

WINDLAS BIOTECH LTD.

NSE : WINDLASBSE : 543329ISIN CODE : INE0H5O01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE764.6527 (+3.66 %)
PREV CLOSE (Rs.) 737.65
OPEN PRICE (Rs.) 740.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1963
TODAY'S LOW / HIGH (Rs.)740.20 774.35
52 WK LOW / HIGH (Rs.)699.35 1137.6
NSE767.6530.9 (+4.19 %)
PREV CLOSE( Rs. ) 736.75
OPEN PRICE (Rs.) 747.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 22215
TODAY'S LOW / HIGH(Rs.) 743.20 775.00
52 WK LOW / HIGH (Rs.)697.4 1140

Quarterly Results

Quarters
Select year
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
2331.02
2223.98
2100.90
2027.05
Total Expenditure
2087.25
1938.42
1835.66
1771.57
PBIDT (Excl OI)
243.77
285.56
265.24
255.48
Other Income
45.70
36.45
52.39
49.37
Operating Profit
289.47
322.01
317.63
304.85
Interest
12.77
10.16
10.58
13.27
Exceptional Items
NA
NA
NA
NA
PBDT
276.70
311.85
307.05
291.58
Depreciation
76.99
75.97
74.48
83.35
Profit Before Tax
199.71
235.88
232.57
208.23
Tax
49.69
57.88
55.93
45.42
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
150.02
178.00
176.64
162.81
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
150.02
178.00
176.64
162.81
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
150.02
178.00
176.64
162.81
Equity Capital
105.39
105.39
104.80
104.80
Face Value (IN RS)
5.00
5.00
5.00
5.00
Reserves
NA
NA
NA
NA
Calculated EPS
7.12
8.44
8.43
7.77
Calculated EPS (Annualised)
28.47
33.78
33.71
31.07
No of Public Share Holdings
8011887.00
8011887.00
7893959.00
7893959.00
% of Public Share Holdings
38.01
38.01
37.66
37.66
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
10.46
12.84
12.63
12.60
PBIDTM%
12.42
14.48
15.12
15.04
PBDTM%
11.87
14.02
14.62
14.38
PBTM%
8.57
10.61
11.07
10.27
PATM%
6.44
8.00
8.41
8.03
 
Notes
Notes
Notes
Notes